ARIPIPRAZOLE 5 MG TAB,MESALAMINE 400 GM TAB,CARVEDILOL 12.5 MG TAB,CYPROHEPTADINE 4 MG TAB,DAPAGLIF
Indian Army
PATIALA, PUNJAB
Bid Publish Date
23-Jun-2025, 11:51 am
Bid End Date
16-Jul-2025, 12:00 pm
EMD
₹7,176
Location
Progress
RAQuantity
928760
Category
ACALABRUTINIB 100 MG CAP
Bid Type
Two Packet Bid
Indian Army announces a tender for ACALABRUTINIB 100 MG CAP, ALPHA KETOANALOGUE 200 MG TAB, CALCIUM ACETATE 500 MG TAB, CARBIDOPA 25 MG plus LEVODOPA 100 MG CR TAB, CILNIDIPINE 10 MG TAB, INJ ERYTHROPOIETIN RECOMBINANT HUMAN 5000 IU, INSULIN ACTRAPID 100 IU ML, 3 ML PEN, INSULIN LISPRO BIPHASIC 50 percent 50 per INSULIN LISPRO AND 50 per INSULINE LISPRO PROTAMINE SUSPENSION 100IU ML, 3ML CART HUMALOG MIX 50 3ML CART, LENVATINIB 4MG TAB, METHYLCOBALAMIN 500MG TAB, MYCOPHENOLATE SODIUM 250MG TAB, NINTEDANIB 150 MG CAP in CENTRAL DELHI, DELHI. Quantity: 928760. Submission Deadline: 16-07-2025 12: 00: 00. Last date to apply is approaching fast!
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
PATIALA, PUNJAB
Indian Army
PATIALA, PUNJAB
Indian Air Force
Rangareddi, TELANGANA
Dg Armed Forces Medical Service
GURDASPUR, PUNJAB
Dg Armed Forces Medical Service
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | ACALABRUTINIB 100 MG CAP | ACALABRUTINIB 100 MG CAP | 600 | no | [email protected] | 15 |
| 2 | ALPHA KETOANALOGUE 200 MG TAB | ALPHA KETOANALOGUE 200 MG TAB | 114,000 | no | [email protected] | 15 |
| 3 | CALCIUM ACETATE 500 MG TAB | CALCIUM ACETATE 500 MG TAB | 134,400 | no | [email protected] | 15 |
| 4 | CARBIDOPA 25 MG plus LEVODOPA 100 MG CR TAB | CARBIDOPA 25 MG plus LEVODOPA 100 MG CR TAB | 39,000 | no | [email protected] | 15 |
| 5 | CILNIDIPINE 10 MG TAB | CILNIDIPINE 10 MG TAB | 305,000 | no | [email protected] | 15 |
| 6 | INJ ERYTHROPOIETIN RECOMBINANT HUMAN 5000 IU | INJ ERYTHROPOIETIN RECOMBINANT HUMAN 5000 IU | 810 | pfs | [email protected] | 15 |
| 7 | INSULIN ACTRAPID 100 IU ML,3 ML PEN | INSULIN ACTRAPID 100 IU ML,3 ML PEN | 300 | no | [email protected] | 15 |
| 8 | INSULIN LISPRO BIPHASIC 50 percent 50 per INSULIN LISPRO AND 50 per INSULINE LISPRO PROTAMINE SUSPENSION 100IU ML,3ML CART HUMALOG MIX 50 3ML CART | INSULIN LISPRO BIPHASIC 50 percent 50 per INSULIN LISPRO AND 50 per INSULINE LISPRO PROTAMINE SUSPENSION 100IU ML,3ML CART HUMALOG MIX 50 3ML CART | 2,460 | pfs | [email protected] | 15 |
| 9 | LENVATINIB 4MG TAB | LENVATINIB 4MG TAB | 2,310 | no | [email protected] | 15 |
| 10 | METHYLCOBALAMIN 500MG TAB | METHYLCOBALAMIN 500MG TAB | 316,000 | no | [email protected] | 15 |
| 11 | MYCOPHENOLATE SODIUM 250MG TAB | MYCOPHENOLATE SODIUM 250MG TAB | 10,200 | no | [email protected] | 15 |
| 12 | NINTEDANIB 150 MG CAP | NINTEDANIB 150 MG CAP | 3,680 | no | [email protected] | 15 |
Start
26-Jul-2025, 1:00 pm
End
28-Jul-2025, 2:03 pm
Duration: 50 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 05-07-2025 14:58:19 | Evaluated |
| 2 | ********** Under PMA | - | 15-07-2025 19:08:39 | Evaluated |
| 3 | ********** Under PMA | - | 09-07-2025 16:41:29 | Evaluated |
| 4 | ********** Under PMA | - | 16-07-2025 11:02:32 | Evaluated |
| 5 | ********** Under PMA | - | 02-07-2025 20:05:44 | Evaluated |
| 6 | ********** Under PMA | - | 16-07-2025 11:22:36 | Evaluated |
| 7 | ********** Under PMA | - | 15-07-2025 13:45:03 | Evaluated |
| 8 | ********** Under PMA | - | 15-07-2025 15:30:28 | Evaluated |
| 9 | ********** Under PMA | - | 15-07-2025 23:06:33 | Evaluated |
| 10 | ********** Under PMA | - | 16-07-2025 11:59:16 | Evaluated |
| 11 | ********** Under PMA | - | 16-07-2025 11:15:10 | Evaluated |
| 12 | ********** Under PMA | - | 15-07-2025 20:25:27 | Evaluated |
| 13 | ********** Under PMA | - | 12-07-2025 16:42:06 | Evaluated |
| 14 | ********** Under PMA | - | 14-07-2025 21:30:56 | Evaluated |
| 15 | ********** Under PMA | - | 16-07-2025 01:30:29 | Evaluated |
| 16 | ********** Under PMA | - | 16-07-2025 10:40:17 | Evaluated |
| 17 | ********** Under PMA | - | 15-07-2025 13:54:05 | Evaluated |
| 18 | ********** Under PMA | - | 15-07-2025 14:15:17 | Evaluated |
| 19 | ********** Under PMA | - | 14-07-2025 14:42:03 | Evaluated |
| 20 | ********** Under PMA | - | 15-07-2025 13:11:43 | Evaluated |
| 21 | ********** Under PMA | - | 16-07-2025 11:33:18 | Evaluated |
| 22 | ********** Under PMA | - | 16-07-2025 11:28:32 | Evaluated |
| 23 | ********** Under PMA | - | 02-07-2025 13:08:05 | Evaluated |
| 24 | ********** Under PMA | - | 16-07-2025 10:35:22 | Evaluated |
| 25 | ********** Under PMA | - | 15-07-2025 17:44:25 | Evaluated |
Key insights about DELHI tender market
The eligibility requirements include being a registered pharmaceutical manufacturer or supplier with relevant licenses and regulatory approvals, specifically from the Drug Control General of India (DCGI), and demonstrating experience in supplying pharmaceuticals to healthcare institutions or government entities.
All bidders must ensure that their offered products comply with the quality standards outlined in the Drug and Cosmetics Act. This includes providing certificates of analysis and ensuring that all medications are not past their expiration dates while meeting all compliance requirements set forth by regulatory bodies.
The payment terms will typically include upfront payment upon contract signing and subsequent payments post-delivery and inspection of the pharmaceutical products. The specifics of the payment process, including timelines and conditions, will be clarified in the awarded contract documentation.
The Earnest Money Deposit (EMD) is a critical requirement intended to secure the bid proposal and ensure commitment from bidders to fulfill the terms of the tender upon winning the contract. The EMD will be retained until the successful execution of the contract or refunded as per the tender guidelines.
Yes, the tender explicitly aims to support Micro, Small, and Medium Enterprises (MSEs) and may provide advantages such as preferential consideration in the evaluation process. Startups are also encouraged to participate, aligning their offerings with the tender's specifications and supporting the government’s initiatives to bolster local businesses.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS